Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Demo Page
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Biosimilar Preference List
Do Not Crush
High Cost Drugs
LASA
Non-Formulary
Therapeutic Interchange
REMS
Renal Dosing
Restricted
Questions & Suggestions (Position 3)
Hazardous Drugs
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Demo Page
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Biosimilar Preference List
Do Not Crush
High Cost Drugs
LASA
Non-Formulary
Therapeutic Interchange
REMS
Renal Dosing
Restricted
Questions & Suggestions (Position 3)
Hazardous Drugs
Search results for:
dorzolamide-timolol ophthalmic
dorzolamide-timolol ophthalmic
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Dorzolamide-Timolol Maleate
SOLUTION, OPHTHALMIC
2.23%-0.68%
VIEW MORE
Carbonic Anhydrase Inhibitors
Additional Information:
Drug Name
Common Side Effects
dorzolamide-timolol ophthalmic
burning sensation of eyes
stinging of eyes
blurred vision
Last updated:
Aug. 22, 2022
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Add Formweb to your mobile device
dorzolamide-timolol ophthalmic